By Sabela Ojea

 

GlaxoSmithKline PLC said Wednesday that the resolution to approve its directors' remuneration report passed at its general meeting with a low vote count, noting that it will continue explaining the rationale for the changes to shareholders.

The British pharma major said that the resolution only got the support of 61.76% of the vote count.

"The company undertook an in-depth consultation process with the majority of its largest shareholders in developing the revised policy and will continue to engage to ensure it fully understands the views of all shareholders on these matters," the FTSE 100 listed company said.

 

Write to Sabela Ojea at sabela.ojea@wsj.com; @sabelaojeaguix

 

(END) Dow Jones Newswires

May 04, 2022 13:28 ET (17:28 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Historical Stock Chart
From Jun 2022 to Jul 2022 Click Here for more Gsk Charts.
Gsk (LSE:GSK)
Historical Stock Chart
From Jul 2021 to Jul 2022 Click Here for more Gsk Charts.